Skip to content

Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor

Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor - Randomized controlled trial comparing the usefulness of endoscopic ultrasound processor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000031373
Enrollment
40
Registered
2018-02-19
Start date
2016-11-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lesions of gastro-intestinal tract, pancreatobiliary and lymph node needed endoscopic ultrasonography(EUS) and EUS-FNA

Interventions

A doctor who has experienced EUS and EUS-FNA for more than 3 years perform EUS (using EU-ME2) in outpatient or inpatient, and EUS-FNA (using SU-1) in inpatient. Image findings, scope insertability, an

Sponsors

Tottori University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Men and women over 20 years old at the time we acquire informed consent 2)Patient who require EUS and EUS-FNA clinically(below) Those who suspect the presence of lesions in the gastrointestinal tract, gall bladder / bile duct, pancreas, lymph node and need detailed observation. Those who needs histopathological diagnosis of lesion. Those who judged clinically that EUS / EUS-FNA is necessary other than the above.

Exclusion criteria

Exclusion criteria: 1) Those who cannot obtain informed consent from this research. 2) Women who may be pregnant or have a possibility of pregnancy. 3) Those who judged inappropriate patient as research subject by the research doctor.

Design outcomes

Primary

MeasureTime frame
Drawability of EUS

Secondary

MeasureTime frame
Insertability and visibility for GI tract. Complication due to this study.

Countries

Japan

Contacts

Public ContactHiroki Koda

Tottori University Hospital Department of Gastroenterology

po.polnga.3.negaiwo.xxx@gmail.com0859-38-6527

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026